Abundance of ADAM9 transcripts increases in the blood in response to tissue damage
Open Access
- 9 April 2015
- journal article
- Published by F1000 Research Ltd in F1000Research
- Vol. 4, 89
Abstract
Background: Members of the ADAM (a disintegrin and metalloprotease domain) family have emerged as critical regulators of cell-cell signaling during development and homeostasis. ADAM9 is consistently overexpressed in various human cancers, and has been shown to play an important role in tumorigenesis. However, little is known about the involvement of ADAM9 during immune-mediated processes. Results: Mining of an extensive compendium of transcriptomic datasets led to the discovery of gaps in knowledge for ADAM9 that reveal its role in immunological homeostasis and pathogenesis. The abundance of ADAM9 transcripts in the blood was increased in patients with acute infection but changed very little after in vitro exposure to a wide range of pathogen-associated molecular patterns (PAMPs). Furthermore it was found to increase significantly in subjects as a result of tissue injury or tissue remodeling, in absence of infectious processes. Conclusions: Our findings indicate that ADAM9 may constitute a valuable biomarker for the assessment of tissue damage, especially in clinical situations where other inflammatory markers are confounded by infectious processes.Keywords
This publication has 34 references indexed in Scilit:
- DAMPs as mediators of sterile inflammation in aging-related pathologiesAgeing Research Reviews, 2015
- Systems Scale Interactive Exploration Reveals Quantitative and Qualitative Differences in Response to Influenza and Pneumococcal VaccinesImmunity, 2013
- Upregulation of α-synuclein during localized radiation therapy signals the association of cancer-related fatigue with the activation of inflammatory and neuroprotective pathwaysBrain, Behavior, and Immunity, 2013
- LPS activates ADAM9 dependent shedding of ACE from endothelial cellsBiochemical and Biophysical Research Communications, 2012
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosisNature, 2010
- Divergence of Macrophage Phagocytic and Antimicrobial Programs in LeprosyCell Host & Microbe, 2009
- ADAM9 Expression is a Significant and Independent Prognostic Marker of PSA Relapse in Prostate CancerEuropean Urology, 2008
- Cell-specific expression and pathway analyses reveal alterations in trauma-related human T cell and monocyte pathwaysProceedings of the National Academy of Sciences, 2006
- Adam‐9 expression and regulation in human skin melanoma and melanoma cell linesInternational Journal of Cancer, 2005
- Involvement of ADAM9 in Multinucleated Giant Cell Formation of Blood MonocytesCellular Immunology, 2001